218780-53-1 Usage
General Description
1-N-(Methylsulfonyl)-4-piperidinone is a chemical compound often used in the field of organic chemistry, specifically in the synthesis of various pharmaceuticals due to its versatile nature. This chemical compound belongs to the class of organic compounds known as piperidinones, which are compounds containing a piperidinone ring, a six-membered saturated ring with one nitrogen atom, one ketone group and four carbon atoms. Its sulfur-containing sulfonyl functional group makes it a good leaving group, thus it's frequently used in nucleophilic substitution reactions. It's also important to note that, like all chemicals, improper handling of 1-N-(Methylsulfonyl)-4-piperidinone has associated health risks, hence it should be used in compliance with safety precautions.
Check Digit Verification of cas no
The CAS Registry Mumber 218780-53-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,8,7,8 and 0 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 218780-53:
(8*2)+(7*1)+(6*8)+(5*7)+(4*8)+(3*0)+(2*5)+(1*3)=151
151 % 10 = 1
So 218780-53-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H11NO3S/c1-11(9,10)7-4-2-6(8)3-5-7/h2-5H2,1H3
218780-53-1Relevant articles and documents
PROCESS FOR THE PREPARATION OF CATHEPSIN S INHIBITORS
-
Page/Page column 128-129, (2011/02/24)
Inhibitors of Cathepsin S enzyme and their synthetic processes.
TETRAHYDRO-PYRAZOLO-PYRIDINE THIOETHER MODULATORS OF CATHEPSIN S
-
Page/Page column 14, (2009/04/24)
Tetrahydro-pyrazolo-pyridine thioether compounds are described, which are useful as cathepsin S modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by ca
BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S
-
Page/Page column 11, (2008/12/08)
Biaryl-substituted tetrahydro-pyrazolo-pyridine compounds are described, which are useful as cathepsin S modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions media